Product Offerings
Product Categories:
animal nutrition, feed additives, pet care
Products:
Plant Protein: DaBomb-P (Livestock), DaBomb-P (Aqua)
Antibiotics Alternatives: DBT-100 HT, DBT-100 LS
Pet Care: LACTOTIDES HEALTH A+, Liqui-TIDE bandages
animal nutrition, feed additives, pet care
Plant Protein: DaBomb-P (Livestock), DaBomb-P (Aqua)
Antibiotics Alternatives: DBT-100 HT, DBT-100 LS
Pet Care: LACTOTIDES HEALTH A+, Liqui-TIDE bandages
DaBomb Protein Biotech Corp., headquartered in Tainan, Taiwan, is a leading biotechnology company specializing in innovative protein-based solutions for animal nutrition, health, and welfare. Established with the goal of revolutionizing livestock and aquaculture feed through sustainable and effective protein alternatives, DaBomb Protein has built a strong reputation for its research-driven approach and cutting-edge biotechnologies.
DaBomb Protein focuses on the development and commercialization of functional proteins, antibiotics alternatives, and pet care solutions. The company's expertise lies in bioactive peptides, fermentation technology, and protein hydrolysis, which enable the production of high-quality, digestible, and sustainable protein sources for livestock and aquaculture.
With a science-backed approach, DaBomb Protein aims to replace conventional antibiotics and chemical feed additives with safe, natural, and highly effective alternatives. This approach aligns with the growing global demand for antibiotic-free and sustainable animal nutrition solutions.
DaBomb Protein’s product portfolio is categorized into three major segments:
DaBomb Protein has a strong global presence, with a key focus on Southeast Asia, Europe, and North America. The company actively exports its products to markets where sustainable livestock and aquaculture feed solutions are in high demand.
According to global trade data sources, DaBomb Protein has successfully completed over 500 international shipments in the last five years, with a consistent year-on-year growth in export volume. The company collaborates with major distributors and feed manufacturers, ensuring widespread adoption of its innovative solutions.
DaBomb Protein has demonstrated robust financial performance, with an estimated revenue of $25 million USD in the last fiscal year. The company has achieved an average annual revenue growth of 15%, driven by increasing demand for antibiotic-free animal nutrition products.
The company's investment in R&D accounts for nearly 12% of its total revenue, highlighting its commitment to continuous innovation and product development.
DaBomb Protein maintains the highest standards of quality and compliance, ensuring its products meet global regulatory requirements. The company holds certifications including:
These certifications reinforce DaBomb Protein’s commitment to safety, efficacy, and ethical production practices.
The company collaborates with leading academic institutions and research centers, including the National Taiwan University and Taiwan Agricultural Research Institute, to develop next-generation feed solutions. DaBomb Protein has secured multiple patents in bioactive peptide technology, further solidifying its position as a pioneer in biotechnology-driven animal nutrition.
DaBomb Protein has earned strong endorsements from industry professionals, including large-scale feed manufacturers and livestock producers.
DaBomb Protein Biotech Corp. continues to lead the industry with science-driven solutions that enhance animal health, promote sustainable farming practices, and deliver value to feed manufacturers and livestock producers worldwide.